Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/2003
10/08/2003EP1350798A1 Allergenic protein HEV b III of natural rubber latex, its production and use in assays
10/08/2003EP1350797A1 Allergenic protein Hev b II of natural rubber latex, its production and use in assays
10/08/2003EP1350795A1 Method of constructing three-dimensional structure of transmembrane protein
10/08/2003EP1350106A2 Ultra-sensitive detection systems
10/08/2003EP1349920A2 Adenylate cyclases
10/08/2003EP1349868A1 Process to concentrate insoluble proteins by vibrating membrane filtration
10/08/2003EP1349829A2 Catalyst modification to enhance neotame production
10/08/2003EP1349569A2 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
10/08/2003EP1141137B1 Water-soluble rhodamine dyes and conjugates thereof
10/08/2003EP0670898B1 Interleukin-3 (il-3) mutant polypeptides
10/08/2003EP0650364B1 Purification of factor ix
10/08/2003EP0607392B1 Plasma fraction purification
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003EP0551460B2 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV)
10/08/2003CN1447817A Method for producing peptide salts. their use, and pharmaceutical prepns. containing these peptide salts
10/08/2003CN1446911A Method for producing protease of thermophilic bacteria by using artificial gene
10/08/2003CN1446823A Overreationg factor as well as its preparation factor and gene
10/08/2003CN1123639C Human activated protein C and its prepn. process
10/07/2003US6631332 Geometric representations in three-dimensional space; data processing, computer programs
10/07/2003US6630570 Of tumor cells and tissues; derived from vaso-active intestinal protein, somatostatin or neurotensin; methine/cyanine; useful for endoscopy
10/07/2003US6630487 Treatment of insulin resistance with growth hormone secretagogues
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630006 Generating crystal structure of preferential protein; form layouts, obtain protein, incubate in mother liquor solution, allow crystals to form, generate images of cystal drops
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081261A2 Microdevices having a preferential axis of magnetization and uses thereof
10/02/2003WO2003081242A1 Caspr3: modulators of angiogenesis
10/02/2003WO2003080852A1 Process for the preparation of a desired erythropoietin glyco-isoform profile
10/02/2003WO2003080793A2 Treating solution containing aluminium ion for staining protein and staining method using the same
10/02/2003WO2003080655A1 A mutated immunoglobulin-binding protein
10/02/2003WO2003080653A1 Novel polypeptide scaffolds and use thereof
10/02/2003WO2003080651A1 Purification of proteins using ionic surfactants and polar solvents
10/02/2003WO2003080650A1 Compounds comprising pseudo-amino acids
10/02/2003WO2003080602A1 Maleic acid salt of (2s)-n-{5-[amino(imino)methyl]-2-thienyl}methyl-1-{(2r)-2-[(carboxymethyl)amino]3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for
10/02/2003WO2003080563A1 Production of carboxylic acid amides
10/02/2003WO2003080544A1 Radiofluorination methods
10/02/2003WO2003080209A2 Method of concentrating macromolecules or agglomerates of molecules or particles
10/02/2003WO2003080141A1 Biomatrix and method for producing the same
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003010512A3 High-speed, solid-liquid separation
10/02/2003WO2002096935A3 Long lasting fusion peptide inhibitors for hiv infection
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002020564A3 A method for identifying peptide sequences having a specific functionality
10/02/2003US20030187270 Therapy for nicotine dependency
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187227 Solid phase synthesis
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187188 Synthesis of peptoid substituted azole compounds
10/02/2003US20030187186 Glycopeptide and preparation thereof
10/02/2003US20030186896 Crystalline form of perindopril tert-butylamine salt
10/02/2003US20030186893 Purified lh
10/02/2003US20030186847 Insulin derivatives and synthesis thereof
10/02/2003US20030186427 Apparatus for selectively converting photogenerated reagent precursors to photogenerated reagents associated with parallel synthesis of molecular sequence arrays on solid surfaces
10/02/2003US20030186408 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186407 Comprises membrane protein for use as antitumor/antiproliferative/antiinflammatory/anticarcinogenic agents
10/02/2003US20030186367 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030186366 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment
10/02/2003US20030186329 Bacteriophage display library which comprises peptide substrates for elucidating specificity differences between closely related enzymes and making enzyme inhibitors based on those differences
10/02/2003US20030186326 Materials and methods for controlling isotope effects during fractionation of analytes
10/02/2003US20030186296 Microarray comprised of polynucleotide or polypeptide biopolymer substrate for use in cancer diagnosis
10/02/2003US20030185862 Fusion peptide of human type- I collagen derived peptide and Tat peptide, preparation therof, and skin anti-aging cosmetic composition comprising the same
10/02/2003US20030185856 Immunizing young hens with antigen proteins of E. coli
10/02/2003US20030185821 Antibodies to interleukin-4 receptors and uses thereof
10/02/2003US20030185798 Biocompatible polymers including peptide spacer
10/02/2003US20030185792 Mimic or enhance the physiological effects of a morphogenic protein, for example OP-1.
10/02/2003CA2480049A1 Novel polypeptide scaffolds and use thereof
10/02/2003CA2479896A1 A mutated immunoglobulin-binding protein
10/02/2003CA2479893A1 Maleic acid salt of (2s)-n-{5-¬amino(imino)methyl|-2-thienyl}methyl-1-{(2r)-2-¬(carboxymethyl)amino|3,3-diphenylpropanoyl}-2-pyrrolidine carboxamide and a process for preparing the same
10/02/2003CA2479891A1 Microdevices having a preferential axis of magnetization and uses thereof
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1064066B1 Adsorption chromatography
10/01/2003EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins
10/01/2003EP0912612B1 Simplified production of bispecific antibody fragments
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003CN1446229A Somatostatin analogues
10/01/2003CN1444991A Preparing method and usage of cardiotoxin
10/01/2003CN1122532C Pigment marked protein composite and its preparing method
09/2003
09/30/2003US6627609 Peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone- dependent tumours and
09/30/2003CA2168382C Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine
09/30/2003CA2141439C Method for highly purifying human serum albumin
09/30/2003CA2102697C Pyrrolidine derivatives, preparation thereof and drugs containing same
09/25/2003WO2003078628A1 Methods for peptide and protein display in nucleic acid arrays
09/25/2003WO2003078470A1 Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same
09/25/2003WO2003078464A2 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods
09/25/2003WO2003078454A2 Polymer supported reagents for natural products purification
09/25/2003WO2003059954A3 Method for specifically immobilizing mediator molecules on substrate surfaces
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002026982A3 Secreted human proteins
09/25/2003US20030182068 Device and methods for directed synthesis of chemical libraries
09/25/2003US20030181753 Method for producing amides or esters
09/25/2003US20030181703 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181702 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181701 PRO polypeptides; fused to heterologous polypeptide sequences
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 518